« Previous
Next »
Journal of Pediatric Health Care
Volume 23, Issue 5
, Pages 327-332
, September 2009
An Unexpected Cause of Chronic Dysphonia in a 10-year-old Boy
References
- Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clinical Pharmacology & Therapeutics. 2003;73:372–382
- . Management of dysphonia in children. The Journal of Laryngology & Otology. 2009;1:1–6
- . Diagnosis and treatment of severe pediatric pulmonary hypertension. Cardiology in Review. 2001;9:227–237
- . Medical and surgical treatment of pediatric dysphonia. Otolaryngologic Clinics of North America. 2000;33:1111–1126
- . Disorders of phonation in children. Pediatric Clinics of North America. 2003;50:363–380
- . Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects. Journal of Cardiothoracic and Vascular Anesthesia. 2007;21:203–207
- . Pulmonary hypertension in children. Current Paediatrics. 2006;16:237–247
- . Pulmonary arterial hypertension in children. Current Opinion in Pediatrics. 2008;20:288–293
- . Pulmonary arterial hypertension in children. Pediatric Pulmonology. 2004;38:2–22
- . Outcomes in children with idiopathic pulmonary arterial hypertension. Circulation. 2004;110:660–665
- . Answer to case of the month #120 Ortner's syndrome (cardiovocal syndrome). Canadian Association of Radiologists Journal. 2005;56:173–174
Note: The Figure is available in color online at www.jpedhc.org.
PII: S0891-5245(09)00099-6
doi: 10.1016/j.pedhc.2009.03.008
© 2009 National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Pediatric Health Care
Volume 23, Issue 5
, Pages 327-332
, September 2009
